These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37060264)

  • 1. In vitro and ex vivo antibacterial activity of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits (Oryctolagus cuniculus) - A preliminary study.
    Sitovs A; Skadins I; Purvina S; Bandere D
    J Vet Pharmacol Ther; 2023 Sep; 46(5):332-343. PubMed ID: 37060264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials.
    Raemdonck DL; Tanner AC; Tolling ST; Michener SL
    Avian Dis; 1992; 36(4):964-7. PubMed ID: 1336664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis.
    Wei XY; Zhang J; Zhang Y; Fu WZ; Zhong LG; Pan YD; Sun J; Liao XP; Liu YH; Zhou YF
    BMC Vet Res; 2024 Apr; 20(1):147. PubMed ID: 38643185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.
    Lu TY; Sun Z; Liang LY; Zhang J; Guo WL; Wang ZY; Sun J; Liao XP; Zhou YF
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38925653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing tylosin dosage for co-infection of
    Lee EB; Abbas MA; Park J; Tassew DD; Park SC
    Front Pharmacol; 2023; 14():1258403. PubMed ID: 37808183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and resistance of chicken Escherichia coli, Salmonella spp., and Pasteurella multocida isolates.
    Huang TM; Lin TL; Wu CC
    Avian Dis; 2009 Mar; 53(1):89-93. PubMed ID: 19432009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance of Pasteurella multocida isolated from diseased food-producing animals and pets.
    Bourély C; Cazeau G; Jouy E; Haenni M; Madec JY; Jarrige N; Leblond A; Gay E
    Vet Microbiol; 2019 Aug; 235():280-284. PubMed ID: 31383313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
    Dorey L; Hobson S; Lees P
    Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.
    Ni W; Song X; Cui J
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):385-9. PubMed ID: 24036892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
    Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
    Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of MIC as sole metric of pharmacodynamic response across the range of antimicrobial susceptibilities within a single bacterial species.
    Wen X; Gehring R; Stallbaumer A; Riviere JE; Volkova VV
    Sci Rep; 2016 Dec; 6():37907. PubMed ID: 27905408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
    Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
    J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.